Sean Wetterer, Phd, Mba Email & Phone Number

Boston, Massachusetts, Us

Us

• Chief of Staff to the CSO. Responsible for oversight and optimization of key research operations (budget, personnel, facilities, communications, IT solutions, research and alliance portfolios). Supervised >2x increase in staffing, budget, and number of active projects with no disruptions during tenure.• Led critical programs and progression of select small molecule and gene therapy vector candidates with timeline and resource management through Phase 2 clinical studies. Supported IND preparation/filing.• Developed Long-Range Plan for Research. Identified sustainable levels of headcount and operational spending to achieve goals for nominations, validations, and identification of development candidates.• Implemented dashboards, valuations, and improved reporting of research project and portfolio status. Coordinated with EC and Development group to provide greater visibility on technology transfer.• Developed data management policy and guidance for Discovery function. Consolidated multiple ELN and LIMS systems to eliminate redundancy, improve data access, and implement automated data analysis. • Established working groups to regularly review and reprioritize projects related to IT and facility infrastructure. Project completion rates greatly improved along with stakeholder satisfaction.• Responsible for planning and execution of major communications campaigns and town-hall events including PTC’s 25th anniversary celebration and annual Science Forum offsite meetings.

New York, New York, Us

• Led ‘Vision 2021’ portfolio refresh that established go-forward priorities for innovation. Identified opportunities for synergies between IFF and DuPont N&B research teams in anticipation of merger close. • Reviewed ideation workflows within IFF to improve alignment between R&D and business units. Increased portfolio value by 38% in 3 years, enhanced speed to market, and facilitated reporting.• Benchmarked IFF’s approach to funding of high risk, high potential “Breakthrough” projects. Implemented investment recommendations and formalized risk assessment criteria.• Established industry surveillance program to monitor competitive research and business activity. Strategic implications assessed and reported to the IFF Executive Committee each quarter.

New York, New York, Us

• Global R&D Leader for Scent Modulation Platform. Championed commercialization of Anomix and Rejuvinex technologies, which strengthened IFF’s IP portfolio and relationships with key customers. • Led technical collaboration with Evolva to optimize production of bioequivalent vanillin by GMO fermentation to address market opportunity of $50 MM/yr and improve stability of supply. • Developed partnerships (BASF, Clariant, Corbion) to create combined solutions for major CPG customers. Resulting technologies enhanced performance while reducing cost and complexity.• Conducted review of potential acquisition targets to expand Delivery Technology capabilities. Purchase of PowderPure enhanced strategic positioning and increased corporate revenue by $75 MM/yr.

New York, New York, Us

• Served as Acting Director of the Fragrance Performance group (2014-2015), managing five direct reports and overseeing activity on Performance Insights and Protein & Texture Platforms. • Led research collaboration with University of Arizona on impact of microbial activity on key consumer “magic moments” for fabric care. Resulting insights yielded new IP and market opportunities.• Established onsite olfactometry capability to improve experimental sensitivity and throughput by 10x.• Developed standardized communications and branding to create consistent global identity for malodor control technology product line. Repositioned and relaunched ActivFresh, Reactek brands.

North Brunswick, Nj, Us

• Provided leadership for an organization of over 300 employees and a multi-million dollar operating budget. Responsible for key strategic decisions as member of the Chromocell Management Team.• Implemented structural initiatives to develop Gustatech into a full-service CRO and to expand client base beyond parent company. Engaged with General Mills, Ajinomoto, and other leading food companies.• Developed novel protocols for high throughput screening in a clinical setting in order to provide industry-leading test reliability and speed of execution.

Brentford, Middlesex, Gb

• Lead developer for three denture care products scheduled for global launch in 2011/2012, each projected to contribute $25 - $50 MM in annual sales and provide a foundation for future line extensions.• Established and operated a cell culture testing facility to accelerate product development. Championed usage of in-vitro assays for biological claim support to eliminate risk and delay of clinical testing.• Created role of Scientific Communications Coordinator. Strategically aligned over 20 scientific presentations with product launch schedule and professional detailing strategy to maximize impact.

Brentford, Middlesex, Gb

• Established strategic roadmap for new product innovation on enhanced fluoride uptake (toothpastes) and oral malodor control (mouth rinses) within a $700 MM/yr global brand.• Conducted due diligence and assessed market potential of the technology licensed for Aquafresh Whitetrays. Product achieved first year sales of $60 MM and outperformed Crest Whitestrips.• Championed the relaunch of Aquafresh Advanced to reverse years of declining brand sales in the US. Directed three clinical studies to establish the basis for product claims of “25% stronger enamel”. • Represented GSK on the CHPA/CTFA Anticaries Task Group, responsible for recommendations of alternative biological test methods to the FDA. Served as GSK liaison to USP dentifrice program.

Frankfurt Am Main, Hessen, De

• Developed and commercialized specialty chemical formulations for surface treatment. Resulting products each contributed $0.5 – $2.0 MM/yr in revenue and provided IP and innovation leadership.• Responsible for oversight of technology transfer during merger of Chemetall Oakite and Brent International. Secured and documented internal knowledge prior to restructuring.• Supported implementation of ISO-9000, QS-9000 quality systems and SAP enterprise management.• As member of “Blue Sky Council” (a corporate strategic initiatives group), developed new business models for increasing effectiveness and productivity of technical managers and sales teams.

Espoo, Southern Finland, Fi

New York, New York, Us

Colombes Cedex, Fr

Master Of Science - Ms, Strategic Management

Master Of Business Administration (M.B.A.)

Ph. D., Chemistry

Bs, Chemistry, Engineering & Applied Science (Dual Major)